Ilkka Julkunen
Has grant
Professor of Virology
Research Interests
Explore related searches
Contact this professor
About
Ilkka Julkunen is a Professor of Virology at the University of Turku, Finland. His research areas include viral infections in pediatric care, the impact of high glucose on macrophage pathways, and insights into COVID-19, particularly regarding drug remedies and host cell responses. His recent articles reflect a commitment to advancing the understanding of viral interactions and immune responses. He is dedicated to enhancing clinical practices through innovative research methodologies.
Recent Grants
Grant: Close
Comparative analysis of vaccine and disease induced immunity and immunological evaluation of COVID-19 vaccines on effectiveness and safety
Open Date: 2020-03-01
Close Date: 2022-12-01
Grant: Close
Coronavirus biology: Characteristics of pandemic SARS-CoV-2, development of diagnostics and analysis of immune responses
Open Date: 2020-03-01
Close Date: 2023-12-01
Grant: Close
Innate immune signaling in viral infections: targets influenza and Ebola viruses
Open Date: 2016-01-09
Close Date: 2020-08-31
Grant: Close
submitted by the coordinator
Open Date: 2012-01-09
Close Date: 2015-08-31
Grant: Close
Influenza virus and viral RNA induced activation of innate immunity
Open Date: 2012-01-01
Close Date: 2015-12-31
Articles (3)
Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses
In light of the COVID-19 global pandemic caused by SARS-CoV-2, ongoing research has centered on minimizing viral spread either by stopping viral entry or inhibiting viral replication. Repurposing antiviral drugs, typically nucleoside analogs, has proven successful at inhibiting virus replication. This review summarizes current information regarding coronavirus classification and characterization and presents the broad clinical consequences of SARS-CoV-2 activation of the angiotensin-converting enzyme 2 (ACE2) receptor expressed in different human cell types. It provides publicly available knowledge on the chemical nature of proposed therapeutics and their target biomolecules to assist in the identification of potentially new drugs for the treatment of SARS-CoV-2 infection.
Year:
2023
Collaborators (1)
Kareem Awad
University of Turku
How do I reach out?
Sign in for free to see their profile details and contact information.